Research

This month we have selected two phase-2 trials investigating α-synuclein-binding antibodies as potential disease-modifying treatment of Parkinson’s disease.

Our authors of the month for September conclude that people with Parkinson's Disease and parkinsonism showed a higher risk of SARS-CoV-2 infection throughout the first 15 months of the pandemic.

Our research paper of the month presents the results of the ‘SWIFT direct’ trial, a randomised, open-label, blinded-outcome trial, aiming to investigate whether thrombectomy alone would be non-inferior to thrombectomy plus intravenous alteplase in patients with acute ischaemic stroke due to anterior circulation large vessel occlusion.

The EAN Neuro-covid ReGistrY has now collected over 3,400 cases from more than 40 centres all over the world. Get involved!

EAN is happy to announce its second Science School, taking place in Salzburg, Austria, on 18-20 March, 2023.

Prof. Didier Leys, Editor-in-Chief of the European Jounal of Neurology, talks to the winner of the first EJoN prize, Dr. Jonathan Coutinho.

The Innovative Health Initiative, a public-private partnership between the European Union and the European life science industries, has launched its first call for proposals, including a topic focusing on neurodegenerative diseases.

Our research paper of the month is a meta-analysis investigating the influence of intraventricular fibrinolysis on functional outcomes in patients with intracerebral haemorrhage.

Our authors of the month conducted this study in which COVID-19 patients with neurological symptoms and cognitive impairments, underwent DMI in the subacute stage of the disease.

The EAN Scientific Panel on Palliative Care has been considering the collaboration between neurology and palliative care, particular in the care of people with progressive neurological disease.

One of the goals of the EAN Guideline Production Group (GPG) is to educate EAN members on the process of guideline development. This year, one day prior to the EAN Congress 2022, we held a workshop on guidelines, aiming to familiarise clinicians with the methodology behind guidelines.

Migraine—with and without aura—is one of the most common neurological disorders, affecting millions worldwide. In the past few years, several new studies have been finished and we have got a better insight into the pathophysiology of migraine.

This EAN 2022 symposium on New evidence to tackle major health issues in stroke was organised in cooperation with the European Stroke Organisation.

The session ‘The relevance of gender and diversity in neurology: Why should I care’ took place in Room Budapest and was moderated by EAN Board Member, Prof. Elene Moro.

This interesting symposium, titled 'Coma - what's new?' exposed the landscape of coma and disorders of consciousness regarding clinical, biological and therapeutic aspects.